The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer.
 
Georg A. Bjarnason
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Merck (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Denis Soulieres
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
D. Scott Ernst
No Relationships to Disclose
 
Pawel Zalewski
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Astellas Medivation; Novartis; Pfizer; Sanofi
Research Funding - BMS Brazil (Inst); Exelixis (Inst); Janssen (Inst); Roche (Inst)
 
Christina M. Canil
Honoraria - Bayer; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Merck; Pfizer; Roche
Research Funding - Astellas Oncology (Inst); AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Eric Winquist
Honoraria - Merck
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis (Inst); Medivation (Inst); Oncogenex (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Sebastien J. Hotte
Honoraria - Astellas Scientific and Medical Affairs Inc; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Pfizer
Research Funding - Agensys; AstraZeneca; Bayer; Boehringer Ingelheim; Novartis; Oncogenex; Roche/Genentech; Sanofi
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Roche Canada (Inst); Sanofi (Inst)
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Robyn Jane Macfarlane
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Merck; Novartis Canada Pharmaceuticals Inc; Roche Canada; Sanofi
 
Peter M. Venner
Honoraria - Astellas Pharma; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); BMS Brazil (Inst); Exelixis (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Oncology; Pfizer
 
Anil Kapoor
Honoraria - Pfizer
 
Aaron Richard Hansen
Honoraria - Pfizer
 
Bernhard J. Eigl
Honoraria - Pfizer
 
Piotr Czaykowski
Research Funding - Argos Therapeutics (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst)
 
Ben Boyd
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Naveen S. Basappa
Honoraria - Astellas Pharma; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Novartis